Charged Alpha Stock Encyclopedia

Alcoa Corporation (AA) Q2 2026 — Alcoa (AA) reported a record Q2 2026: revenue $3.97B (+24% QoQ, +31% YoY, a company record), adjusted EBITDA $901M (+51% QoQ), and adjusted EPS $2.12 — but that missed the ~$2.25 Street estimate, and the stock fell ~3.4% to ~$45. GAAP EPS was $1.53 ($407M net income); the 'miss' was driven by $155M of net special items (a $123M Ma'aden mark-to-market loss and $45M...

Intuitive Surgical (ISRG) Q2 2026 — Intuitive Surgical (ISRG) reported a clean Q2 2026 beat: revenue $2.89B (+19% YoY), non-GAAP EPS $2.80 (beat $2.48, +28%), GAAP EPS $2.29; worldwide procedures +16% (da Vinci +15%, Ion +36%); 468 da Vinci systems placed (246 were da Vinci 5) vs 395 a year ago; installed base 11,710 (+12%). Instruments & accessories $1.73B (+18%, ~60% of revenue); non-GAAP gr...

Abbott Laboratories (ABT) Q2 2026 — Abbott (ABT) reported a solid Q2 2026 beat: revenue $12.59B (+13.0% reported, +4.8% organic), adjusted EPS $1.31 (beat $1.28, +4% YoY), adjusted gross margin 58.0% (+100bps). Medical Devices +8.4% (CGM/FreeStyle Libre cleared $2B, +9.5%), Established Pharma +9%, Diagnostics +2.9% organic (+42.3% w/ Exact Sciences), Nutrition -3.6%. It RAISED FY26 adjusted EPS gu...

GE Aerospace (GE) Q2 2026 — GE Aerospace (GE), the pure-play jet-engine giant carved out of the old General Electric, reported a strong Q2 2026: adjusted EPS of $2.02 beat the ~$1.86 estimate (+22% YoY) on adjusted revenue of $12.6B (+24%), orders jumped 17% to $16.5B, operating profit rose 18% to $2.7B, and free cash flow surged 43% to $3.0B. Management RAISED full-year 2026 guidance again — adju...

UnitedHealth Group (UNH) Q2 2026 — UnitedHealth Group (UNH), the largest U.S. health insurer, reported a blowout Q2 2026: adjusted EPS of $6.38 crushed the ~$4.94 estimate and jumped 56% from $4.08 a year ago, as the medical care ratio fell to 86.7% (from 89.4%) and operating profit rose 55% to $8.0B. Management RAISED full-year adjusted EPS guidance to $19.50–$20.00 and doubled buybacks to $5B+....

Taiwan Semiconductor (TSM) Q2 2026 — Taiwan Semiconductor (TSM), the world's dominant chip foundry (~90% of leading-edge manufacturing), reported a big Q2 2026 beat: ADR EPS of $4.31 (vs $3.82 est), with gross margin expanding to 67.7% and a 60.3% operating margin, driven by AI/high-performance-computing demand. The ADR (~$410, ~15% off its $479 high but nearly doubled off its $224 low) dipped ~2%...

Netflix (NFLX) Q2 2026 — Netflix (NFLX) reported Q2 2026 revenue of $12.56B, up 13.4% YoY (roughly in line), with EPS of $0.80 (a penny beat) and a 33.4% operating margin. But the stock fell ~8% after hours on soft Q3 guidance (revenue +11.7% to $12.86B, below ~$13B hoped). It maintained FY2026 guidance (revenue $51.0-51.4B, 31.5% operating margin). Split-adjusted, the shares (~$74) sit near their...

J.B. Hunt Transport (JBHT) Q2 2026 — J.B. Hunt Transport (JBHT), the freight and logistics bellwether, reported Q2 2026 adjusted EPS of $1.91, beating $1.71, with EPS inflecting up from $1.49 the prior quarter and operating margins improving — early signs the multi-year freight recession is turning. The stock popped ~8% to a fresh 52-week high (~$298), having more than doubled off its ~$130 low. B...

United Airlines (UAL) Q2 2026 — United Airlines (UAL) reported a strong Q2 2026: revenue up 16% YoY to $17.7B, adjusted EPS $1.99 (beat $1.91), unit revenue (TRASM) +12.1%, with premium revenue +16%, loyalty +11% and cargo +23%. Most notably, it RAISED full-year 2026 adjusted EPS guidance to $9.00-$11.00 despite absorbing nearly $6B more fuel cost. The stock (~$119, ~14% off its $139 high, ~12x fo...

Cintas (CTAS) Q4 FY2026 — Cintas (CTAS), the uniform-rental and facility-services compounder, reported fiscal Q4 2026: revenue up ~7% to $2.9B, adjusted EPS $1.29 (beat $1.24), operating margin over 23%. The stock popped ~7%. It's a wide-moat, recurring-revenue machine (route density, ~23% margins, cross-selling first aid/safety and fire protection) — one of the best-performing stocks of the past...

Elevance Health (ELV) Q2 2026 — Elevance Health (ELV), one of the largest U.S. health insurers (~46M members, formerly Anthem), reported Q2 2026 adjusted EPS of $7.45, crushing the $6.18 estimate (helped by Carelon pharmacy) — but that was down from $8.84 a year ago, and the stock FELL. Despite the beat, it RAISED full-year adjusted EPS guidance to at least $27.00. The problem: a rising medical lo...

Johnson & Johnson (JNJ) Q2 2026 — Johnson & Johnson (JNJ) reported a clean Q2 2026 beat: sales +6.6% to $25.3B, adjusted EPS $2.90 (+4.7%, ahead of estimates), with Innovative Medicine (pharma) sales +6.8% out-growing the patent cliffs. It RAISED full-year guidance to ~$101.1B sales (+7.3%) and $11.68 adjusted EPS (+8.2%) — on track to cross $100B in annual revenue for the first time in it...

ASML Holding (ASML) Q2 2026 — ASML Holding (ASML) — the sole maker of EUV lithography machines, essential to every advanced AI chip — reported a clean Q2 2026 beat: net sales €9.3B, a 54.0% gross margin (above guidance), and €2.9B net income (EPS €7.59). It RAISED its 2026 outlook to €43-45B sales at 54-56% gross margin, guided Q3 to €11-12B, and said it has substantially all the orders it needs f...

Conagra Brands (CAG) Q4 FY2026 — Conagra Brands (CAG) reported fiscal Q4 2026: net sales +3.6% to $2.9B (organic flat), adjusted EPS $0.47 (a penny beat), but a GAAP loss of $3.37/share from a ~$1.6B non-cash brand impairment. The big news: Conagra cut its annual dividend in half, to $0.70 from $1.40, to fund reinvestment (+$125M capex, +$40M brand) and deleverage toward 3.0x. It guided FY2027 adj...

Sify Technologies (SIFY) Q1 FY2027 — Sify Technologies (SIFY) — an Indian ICT company pivoting hard into data centers for the AI/cloud buildout — reported fiscal Q1 2027 revenue up 15% YoY to INR 12,352M (~$149M), adjusted EBITDA up 42% to ~INR 3,005M (~$36M), and swung to a small net profit (~INR 65M) versus a year-ago loss. Data centers are now 42% of revenue. But quarterly capex (~INR 6,708M /...

Winmark Corporation (WINA) Q2 2026 — Winmark (WINA) — the franchisor behind resale chains Plato's Closet, Once Upon a Child, Play It Again Sports and Style Encore — reported fiscal Q2 2026 revenue up ~7.6% to $22.0M at a ~62% operating margin, with EPS ~$2.81 (roughly flat YoY and a touch light of a thin estimate). The stock rose anyway. It's an asset-light, counter-cyclical royalty machine that r...

Frequency Electronics (FEIM) Q4 FY2026 — Frequency Electronics (FEIM) — a niche maker of atomic clocks and precision timing for satellites, missiles and secure military comms — reported an ugly fiscal Q4: gross margin collapsed to ~1% (vs a normal ~30%) and EPS came in at -$0.50 versus a +$0.27 estimate, a big miss, on a $3.8M Elcom inventory write-down and pre-revenue investment. Strip the one-of...

BitMine Immersion Technologies (BMNR) Q3 FY2026 — BitMine Immersion (BMNR), the largest corporate holder of Ethereum on earth (~5% of all ETH), trades at roughly a 13% discount to the value of its own coins — you buy a dollar of Ethereum for about 87 cents. But it carries an ~$8.2B unrealized loss from buying ETH near the top, and funds itself with 12%-cost preferred to earn a 2.7% staking yield....

Grupo Aeroportuario del Pacífico (PAC) Q2 2026 — Grupo Aeroportuario del Pacífico (GAP), the Mexican airport operator, grew Q2 2026 EBITDA 8.4% to a record 69% margin and net income 9% — even as passenger traffic fell 5.6% — but the stock was labeled an earnings 'miss' because per-share profit fell ~7% after it issued ~90M shares (+17.7%) to buy full control of the CBX border bridge. The ADR was r...

AngioDynamics (ANGO) Q4 FY2026 — AngioDynamics beat on its fiscal Q4 (revenue $86.6M, +8%; adjusted loss of $0.07, 4 cents better than feared), grew full-year Med Tech 18%, and guided FY27 revenue above consensus. The stock jumped ~11% to a 52-week high, led by NanoKnife (+64.5%) as Medicare coverage for its prostate-ablation therapy went live July 5. AngioDynamics quietly reinvented itself: it so...

Phoenix Education Partners (PXED) Q3 FY2026 — Phoenix Education Partners (parent of the University of Phoenix) reported flat Q3 revenue of $271.8M, beat on adjusted EPS at $1.43, but cut its full-year revenue guide and saw margins compress — blaming AI-powered search for disrupting its student-recruitment funnel. The stock fell ~9.5% to ~$31. The single number that governs this stock: 88.6% of Pho...

Ericsson (ERIC) Q2 2026 — Ericsson's Q2 2026 adjusted gross margin rose to 48.4% (Networks 50.4%, a multi-year high) and EPS met consensus, but the ADR fell ~13% — its worst earnings reaction in three years — after management warned that AI-driven memory and component cost inflation will squeeze Q3 Networks margins to 48-50%, revenue came in light, and North America declined. Ericsson beat on prof...

Fastenal Company (FAST) Q2 2026 — Fastenal grew Q2 2026 revenue 14.7% to $2.39B with daily sales up 14.7%, but EPS of $0.33 only met consensus, gross margin fell 75bps to 44.6% on tariff costs, and it trimmed two full-year targets. The stock slipped ~2.2% to ~$44.75. Nobody disputes Fastenal is a wonderful business — 31% return on capital, a genuine vending-machine and Onsite moat, a fortress bala...

Kestra Medical Technologies (KMTS) Q4 FY2026 — Kestra Medical grew fiscal Q4 revenue 66% to $28.6M (FY26 +59% to $95.1M) and expanded gross margin to 54.8% — its 10th straight quarter of gains — but its adjusted EBITDA loss widened to $27M, EPS missed, and it guided FY27 revenue to $137M (+44%, a deceleration). The stock fell ~8.5% to ~$22. Kestra makes the ASSURE wearable defibrillator and is the...

Aehr Test Systems (AEHR) Q4 FY2026 — Aehr Test Systems beat on its fiscal Q4 (revenue $18.8M, +34%; non-GAAP EPS $0.11 vs a small expected loss), posted record bookings of $60.7M and a $100.6M effective backlog, and guided fiscal 2027 revenue to $130-150M — 160-200% growth. The stock rose ~6% to $72. Going into the print, Aehr was the classic story stock: 52x sales, falling revenue, and no FY27 nu...